Rivia

“I think we're no longer perceived as kind of a startup garage type of operation... We're now perceived as a much more professionalized, driven to development type of organization with people who know what they are doing and know how to represent the data.”

“As we were getting ready for our Series C round, we knew that we needed to generate very reliable, clean, crisp visualizations of the data from our Phase 1 study... So Rivia was actually the best resource for this.”

“The allocated time for poster presentations is three or four hours, but we were in front of our poster for over 5 hours with people coming up and asking us questions. We were absolutely mobbed.”

“We were able to organize the poster in such a way that these graphs generated by Rivia were really the highlight, and people spent a lot of time looking at them.”

“Rivia's ability to deliver powerful visualizations and clear data-driven insights is invaluable, especially in early stages of clinical trials. Its flexibility in adapting visual outputs to meet user needs and its efficient patient data management system makes it an essential tool for any biotech focused on making informed, patient-centered decisions.”

“The platform enhances communication with KOLs and investigators by providing a broader, unbiased view of data across sites, which is crucial for cross-site comparisons and deeper insights. Additionally, it reduces the complexity of patient profiles from 50 data listings to a few clicks, enabling clear and flexible data analysis.”

“Rivia streamlines our decision-making process by providing self-explained and flexible visualizations that can be easily understood and adapted based on feedback from key stakeholders like the board. This aids in rapid response and adjustments in our strategic approach.”

“Rivia is pivotal in early-stage clinical development for identifying subtle differences and trends among a limited patient pool. It simplifies complex data into clear visualizations, allowing us to spot important insights swiftly.”

“Rivia gave us one view that brought diaries, labs, safety reports, and imaging together. There was no longer the need to piecing things together.”

“For the first time, I could explore variables myself without waiting on statisticians or programmers. The answers were immediate.”

“We had patient diary data, and because it fed seamlessly into the Rivia platform, we were able to assess patients on a daily basis and measure their disease activity.”

“It enables us to get key relevant information faster than I have ever encountered.”

“Having real-time data allowed us to make key strategic decisions, not only for the clinical trial, but for the company.”

“Board preparation used to take weeks of gathering and reconciling data. With Rivia, it is done in a matter of hours, with more insight than before.”

“I’ve been running trials for more than 20 years. We always had the same problem: fragmented data and a lack of medical oversight. There were no tools that allowed us to truly understand patients across the many different data points. I wanted a comprehensive overview of the data in time. Rivia not only allows me to look at the data I am asking for, but much more importantly, it allows me to explore data and come to insights I had not thought about.”

“I think every medic in the clinical trial, and also clinical leads in trials, should use this kind of software to have a better overview of their data.”

“Try it yourself, and see how it helps. Compare it to other software. I have a lot of experience with other software, and I can tell you the Rivia software sticks out. On top of that, there is the adaptability of the company and the willingness to change things quickly for your specific needs.”

“Rivia stands out because of the well designed views of the data. The software really works always very well. The company is quick in answering questions and understanding the needs of customers, and they are willing to adapt.”

“The Rivia software is actually saving me time, and that's of course, very important. It also allows me to better understand the data because they are integrated and in one view. Combining safety, efficacy, and timing of dosing is really helpful.”

““RIVIA has enabled us to get verified high-integrity data cuts that I’ve been able to share with our board, investors, shareholders, as well as future potential investors.””

““The outcome of Big Data AI really means a quicker time to market, and thus patients are getting access to a medicine much more quickly than they otherwise would.””

““Apart from enabling us to conduct these what can be tedious, painful tasks, it has also been a very pleasant way of doing it, with the huge value of being able to observe and monitor the efforts that the team is putting in.””

““Being able to detect whether or not those have been picked up is incredibly important, because if a sample is missed, we can ask them to perform that at a later datenot too far away from when it should have been scheduled.””

““Being able to identify these potentially before sites have even informed us enables us to support the trial site with rescheduling of that vaccine dose at a later date.””

““We’ve been able to progress at much greater speed than otherwise we would have, without additional consumption of our limited resources.””